Explore more publications!

Funafuti Tech Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Funafuti Tech Report.

Press releases published on March 17, 2026

Neuroscale AI Secures $540,000 DoD SBIR Phase II (D2P2) Award to Advance Secure Multimodal AI for Federal Decision-Making
Cognition Therapeutics Presents Evidence of Zervimesine’s Impact on Neuropsychiatric Symptoms of Dementia with Lewy Bodies at AD/PD 2026
Xtract One Chosen by Morgan County Schools for Amplified Security at District’s High School Campuses
Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference
Abeona Therapeutics® Reports Full Year 2025 Financial Results and Corporate Updates
Kane Biotech Announces Publication in Frontiers in Antibiotics Highlighting Advancements in Treating Antibiotic Tolerant Biofilms
PaymentWorks Customers Now Qualify for Up to $5 Million in Total Fraud Coverage
Clarios Connected Services introduces Battery Manager Pro at TMC 2026
R1 Therapeutics launches with oversubscribed $77.5 million Series A financing to advance first-in-class treatment for hyperphosphatemia in patients with chronic kidney disease
Your360 AI Delivers What Surveys Can't: Team-Level Patterns From Confidential Voice Interviews
Transpire Bio Strengthens its Leadership Team with Appointment of Ewan Livesey as Head of Business Development
Monte Rosa Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Updates
Cambridge Atomworks Sign Agreement with Mott MacDonald for Microreactor Technology
P.S.S. Urology Launches $11.1M Regulation D 506(c) Raise to Accelerate Growth in Urologic Care
Novidea Releases Updated Version of Its Insurance Management Platform with Significant Enhancements Across Policy Administration, Bordereaux, Claims and Accounting
MorningAI Appoints CPG Veteran Tina Wung as Chief Growth Officer
Priavoid Presents Initial Phase 2 Data Suggesting Favorable Safety Profile for Alzheimer’s Candidate PRI-002 at AD/PD™ 2026
BPL-003 Demonstrates Rapid and Durable Antidepressant Effects in Treatment-Resistant Depression; Phase 2a Data Published in Journal of Psychopharmacology; Phase 3 Program on Track for Q2 2026 Initiation
EvoCash Bridges Web3 and Traditional Finance with MSB-Registered Web3-Compliant USD Accounts, Eliminating Crypto-Related Account Freezes
BioCardia Announces Pre-Submission Approval Package for Helix Transendocardial Delivery Catheter Accepted by FDA

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions